JBM Healthcare Announces FY2025 Interim Results
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jbm (2161)
The Jbm share price today is 2.48, view HK 2161 stock exchange data. Track the latest Jbm share price with real-time updates on 2161 stock performance including market cap, day range, 52-week range and dividend yield. Access 2161 charts, earnings dates and analyst estimates to support your investment decisions.
Hong Kong
Currency in HKD
2.48
+0.02(+0.81%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.43
2.56
52 wk Range
2.07
3.43
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.432.56
52 wk Range
2.073.43
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(8.64%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(8.64%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2161 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
3.15
Upside
+27.02%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
- JBM Healthcare Issues Positive Profit Alert
- Investing.com
- JBM Healthcare Announces FY2025 Interim Results
- Investing.com
- JBM Healthcare Issues Positive Profit Alert
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.15
(+27.02% Upside)
Earnings
Latest Release
17-11-2025
EPS / Forecast
0.14 / --
Revenue / Forecast
429.64M / --
Compare 2161 to Peers and Sector
Metrics to compare | 2161 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship2161PeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.3x | 11.5x | −0.5x | |
PEG Ratio | 0.35 | −0.19 | 0.00 | |
Price/Book | 1.9x | 1.0x | 2.6x | |
Price / LTM Sales | 2.5x | 1.7x | 3.2x | |
Upside (Analyst Target) | 27.5% | 50.4% | 47.8% | |
Fair Value Upside | Unlock | 22.6% | 5.9% | Unlock |
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other non-pharmaceutical products for the general health and wellness of consumers. The company also offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and CCMG products. It is also involved in the manufactures, trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Jbm (2161) Share Price Today?
The Jbm share price today is 2.48.
What is the current Jbm (2161) share price and day range?
As of 09-05-2026, the Jbm share price is 2.48, with a previous close of 2.46. The share price has ranged from 2.43 to 2.56 today, while the 52-week range spans from 2.07 to 3.43.
What Is the Jbm Market Cap?
As of today, Jbm market cap is 2.03B.
Does Jbm Pay Dividends? What's The Current Dividend Yield?
The Jbm dividend yield is 8.64%.
What Is the Jbm (2161) Share Price Target?
The average 12-month share price target for Jbm is 3.15, with a high estimate of 3.15 and a low estimate of 3.15. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +27.02% Upside potential.
What Is Jbm's Earnings Per Share (TTM)?
The Jbm EPS (TTM) is 0.25.
From a Technical Analysis Perspective, Is 2161 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Jbm Trade On?
Jbm is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for Jbm?
The stock symbol for Jbm is "2161."
How Many Times Has Jbm Stock Split?
Jbm has split 0 times.
How Many Employees Does Jbm Have?
Jbm has 412 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.